Endospan achieves FDA Approval for NEXUS® Aortic Arch Stent Graft System, Expanding Minimally Invasive Options for High-Risk Patients Endospan, a privately held medical device company based in Tel Aviv, Israel,…
InterVene Reaches Key Milestone with 30 Procedures Using Recana Thrombectomy System InterVene, Inc., a privately held medical device company focused on advancing interventional solutions for venous disease, has announced a…
Bridge Dental Group Expands California Presence with New Glendora Partnerships Bridge Dental Group has announced a significant step forward in its national growth strategy with the addition of two well-established…
OSI Systems, Inc. Wins $40 Million Medical Device Sub-Assembly Contract OSI Systems, Inc., a global provider of specialized electronic systems and components, has announced a significant new business win that…
After an Autism Diagnosis: A Guide for Families Navigating the Next Steps April marks Autism Acceptance Month, a time dedicated not only to raising awareness but also to promoting understanding,…
Allevion Medical Secures FDA Clearance for Vantage™ Disposable System for Spinal Decompression Allevion Medical has announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its…
Premier Radiology Services Acquires Global Imaging Solutions to Expand Teleradiology and Subspecialty Expertise Premier Radiology Services (Premier) has announced the acquisition of Global Imaging Solutions (GLOBIS), a well-established teleradiology provider…
Angelalign Technology (6699.HK) Releases 2025 Results, Clinical Excellence Fuels Global Growth Angelalign Technology has reported strong financial and operational performance for the fiscal year 2025, underscoring its continued expansion in…
Sensus Healthcare Initiates Legal Action Against SkinCure Oncology Over Alleged Contract Breach Sensus Healthcare,a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological…
Lebrikizumab provides up to four years of sustained disease control in moderate-to-severe atopic dermatitis Lebrikizumab Almirall, a global biopharmaceutical company dedicated to advancing medical dermatology, has announced encouraging long-term interim…
GE HealthCare to Lead Major EU IHI Consortium Advancing Cardio-Oncology Care The global healthcare landscape is undergoing a profound transformation, driven by rapid technological advancements and an increasing focus on…
FDA Clears Long Bridge Medical to Launch GOLDEN GATE Pivotal Trial for LensOne™ Prosthetic Capsular Bag Long Bridge Medical, Inc., a U.S.-based medical device innovator focused on advancing ophthalmic surgical…